七、参考文献

七、参考文献

［1］Bruce JP，Hui AB，Shi W，et al.Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma［J］.Oncotarget，2015，6：4537-4550.

［2］Torre LA，Bray F，Siegel RL，et al.Global cancer statistics，2012［J］.CA Cancer J Clin，2015，65：87-108.

［3］Chen W，Zheng R，Baade PD，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66：115-132.

［4］Chua ML，Wee JT，Hui EP，et al.Nasopharyngeal Carcinoma［J］.Lancet.2016，387：1012-1024.

［5］Cao SM，Simons MJ，Qian CN.The prevalence and prevention of nasopharyngeal carcinoma in China［J］.Chinese Journal of Cancer Research，2011，30：114-119.

［6］Sun Y，Li WF，Chen NY，et al.Induction chemotherapy plus concurrent chemoradiotherapy versusconcurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma：a phase 3，multicentre，randomised controlled trial［J］.Lancet Oncol，2016，17：1509-1520.

［7］Wang M，Tian H，Li G，Ge T，Liu Y，Cui J，Han F.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma：a meta-analysis of randomized controlled trials［J］.Oncotarget，2016，7：48375-48390.

［8］DeNittis AS，Liu L，Rosenthal DI，et al.Nasopharyngeal carcinoma treated with external radiotherapy，brachytherapy，and concurrent/adjuvant chemotherapy［J］.Am J Clin Oncol，2002，25（1）：93.

［9］Zhou BB，Elledge SJ.The DNA damage response：putting check-points in perspective［J］.Nature，2000，408（6811）：433-439.

［10］Gerweck LE，Vijayappa S，Kurimasa A，et al.Tumor cell radiosensitivity is a major determinant of tumor response to radiation［J］.Cancer Res.2006，66：8352-8355.

［11］Vaupel P，Hoeckel M.Predictive power of the tumor oxygenation status［J］.Adv Exp Med Biol，1999，471：533-539.

［12］Karar J，Maity A.Modulating the tumor microenvironment to increase radiation responsiveness［J］.Cancer Biol Ther，2009，8（21）：1994-2001.(https://www.daowen.com)

［13］Koch CJ，Kruuv J，Frey HE.Variation in radiation response of mammalian cells as a function of oxygen tension［J］.Radiat Res，1973，53：33-42.

［14］Spannuth W.A.，Sood A.K.& Coleman R.L.Angiogenesis as a strategic target for ovarian cancer therapy［J］.Nat Clin Pract Onco，2008，15：194-204.

［15］Guang-Wu H，Sunagawa M，Jie-En L，et al.The relationship between microvessel density，the expression of vascular endothelial growth factor（VEGF），and the extension of nasopharyngeal carcinoma［J］.Laryngoscope，2000，110（12）：2066-2069.

［16］Hui EP，Chan AT，Pezzella F，et al.Coexpression of hypoxia-inducible factors 1alpha and 2alpha，carbonic anhydraseⅨ，and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival［J］.Clin Cancer Res，2002，8（8）：2595-2604.

［17］Li YH，Hu CF，Shao Q，et al.Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma［J］.J Transl Med，2008，6：1.

［18］Sha D，He YJ.Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma［J］.Ai Zheng，2006，25（2）：229-234.

［19］Jain RK.Normalization of tumor vasculature：an emerging Concept in antiangiogenictherapy［J］.Science，2005，307（5706）：58-62.

［20］Teicher BA，Holden SA，Ara G，et al.Influence of all antiangiogenic treatment on 9L gliosarcoma，oxygenation and response to cytotoxic therapy［J］.Int J Cancer，1995，61（5）：732.

［21］Zhou J，Wang L，Xu X，et al.Antitumor activity of Endostar combined with radiation against humannasopharyngeal carcinoma in mouse xenograft models［J］.Oncol Lett，2012，4（5）：976-980.

［22］Peng QX，Han YW，Zhang YL，et al.Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma［J］.Oncotarget，2017，8（32）：52813-52822.

（杨 峥）